CSBR CHAMPIONS ONCOLOGY, INC.
Nasdaq · SEC CIK 771856 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 64 since 2021-10-13, latest 2026-01-30
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| ACKERMAN JOEL | Dir | — | — |
Transactions 39
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-06 | 2025-10-30 | CSBR | ACKERMAN JOEL | Dir | M - OptEx | $2.10 | +94.4K | 1.06M | +10% | +$198.3K |
| 2025-04-02 | 2025-03-25 | CSBR | Breitfeld Philip P. | Dir | J - Other | $0.00 | -4,150 | 5,717 | -42% | $0 | |
| DM | 2024-11-01 | 2024-10-31 | CSBR | ACKERMAN JOEL | Dir | M - OptEx | $2.63 | +105.1K | 945.5K | +13% | +$276.3K |
| 2024-01-16 | 2024-01-12 | CSBR | Mendelson Daniel Newman | Dir | P - Purchase | $6.50 | +1,000 | 198.6K | +0.5% | +$6,500 | |
| 2024-01-12 | 2024-01-11 | CSBR | Mendelson Daniel Newman | Dir | P - Purchase | $6.27 | +2,000 | 197.6K | +1% | +$12.5K | |
| 2024-01-11 | 2024-01-10 | CSBR | Mendelson Daniel Newman | Dir | P - Purchase | $6.31 | +2,944 | 195.6K | +2% | +$18.6K | |
| 2024-01-10 | 2024-01-09 | CSBR | Mendelson Daniel Newman | Dir | P - Purchase | $6.25 | +3,000 | 192.7K | +2% | +$18.8K | |
| 2024-01-09 | 2024-01-08 | CSBR | Mendelson Daniel Newman | Dir | P - Purchase | $6.15 | +1,000 | 189.7K | +0.5% | +$6,150 | |
| 2024-01-08 | 2024-01-05 | CSBR | Mendelson Daniel Newman | Dir | P - Purchase | $6.09 | +2,000 | 188.7K | +1% | +$12.2K | |
| 2024-01-08 | 2024-01-04 | CSBR | Mendelson Daniel Newman | Dir | P - Purchase | $6.12 | +3,000 | 186.7K | +2% | +$18.4K | |
| D | 2024-01-05 | 2023-10-17 | CSBR | ACKERMAN JOEL | Dir | M - OptEx | $2.10 | +114.6K | 857.0K | +15% | +$240.6K |
| 2024-01-04 | 2024-01-03 | CSBR | Mendelson Daniel Newman | Dir | P - Purchase | $5.83 | +500 | 183.7K | +0.3% | +$2,915 | |
| 2023-12-26 | 2023-12-21 | CSBR | Mendelson Daniel Newman | Dir | P - Purchase | $4.92 | +2,500 | 183.2K | +1% | +$12.3K | |
| 2023-12-21 | 2023-12-20 | CSBR | Mendelson Daniel Newman | Dir | P - Purchase | $4.82 | +2,100 | 180.7K | +1% | +$10.1K | |
| 2023-12-20 | 2023-12-19 | CSBR | Mendelson Daniel Newman | Dir | P - Purchase | $4.75 | +5,000 | 178.6K | +3% | +$23.8K | |
| 2023-10-16 | 2023-09-29 | CSBR | Mendelson Daniel Newman | Dir | P - Purchase | $6.16 | +4,000 | 173.6K | +2% | +$24.6K | |
| 2023-10-16 | 2023-09-28 | CSBR | Mendelson Daniel Newman | Dir | P - Purchase | $6.22 | +5,000 | 169.6K | +3% | +$31.1K | |
| 2023-10-16 | 2023-09-27 | CSBR | Mendelson Daniel Newman | Dir | P - Purchase | $5.95 | +1,500 | 164.6K | +0.9% | +$8,925 | |
| 2023-10-13 | 2023-10-11 | CSBR | Mendelson Daniel Newman | Dir | P - Purchase | $6.40 | +5,000 | 163.1K | +3% | +$32.0K | |
| 2023-10-11 | 2023-10-10 | CSBR | Mendelson Daniel Newman | Dir | P - Purchase | $6.41 | +1,100 | 158.1K | +0.7% | +$7,051 | |
| 2023-10-10 | 2023-10-06 | CSBR | Mendelson Daniel Newman | Dir | P - Purchase | $6.48 | +1,530 | 157.0K | +1.0% | +$9,914 | |
| 2023-10-06 | 2023-10-05 | CSBR | Mendelson Daniel Newman | Dir | P - Purchase | $6.47 | +2,000 | 155.5K | +1% | +$12.9K | |
| 2023-10-04 | 2023-10-04 | CSBR | Mendelson Daniel Newman | Dir | P - Purchase | $6.40 | +5,000 | 153.5K | +3% | +$32.0K | |
| 2023-10-04 | 2023-10-03 | CSBR | Mendelson Daniel Newman | Dir | P - Purchase | $6.30 | +2,500 | 148.5K | +2% | +$15.8K | |
| 2023-09-27 | 2023-09-26 | CSBR | Mendelson Daniel Newman | Dir | P - Purchase | $5.65 | +5,000 | 146.0K | +4% | +$28.2K | |
| 2023-09-25 | 2023-09-19 | CSBR | Mendelson Daniel Newman | Dir | P - Purchase | $5.28 | +5,000 | 128.1K | +4% | +$26.4K | |
| 2023-09-25 | 2023-09-22 | CSBR | Mendelson Daniel Newman | Dir | P - Purchase | $5.50 | +3,812 | 141.0K | +3% | +$21.0K | |
| 2023-09-25 | 2023-09-20 | CSBR | Mendelson Daniel Newman | Dir | P - Purchase | $5.51 | +4,018 | 132.1K | +3% | +$22.1K | |
| 2023-09-25 | 2023-09-21 | CSBR | Mendelson Daniel Newman | Dir | P - Purchase | $5.51 | +5,000 | 137.1K | +4% | +$27.6K | |
| 2023-03-21 | 2023-03-17 | CSBR | Morris Ronnie | CEO, Dir | P - Purchase | $4.04 | +12.4K | 858.9K | +1% | +$50.0K | |
| D | 2022-10-20 | 2022-10-19 | CSBR | ACKERMAN JOEL | Dir | M - OptEx | $3.21 | +16.7K | 1.46M | +1% | +$53.5K |
| D | 2022-10-14 | 2022-10-12 | CSBR | Breitfeld Philip P. | Dir | F - Tax | $7.51 | -3,562 | 14.6K | -20% | -$26.8K |
| D | 2022-10-14 | 2022-10-12 | CSBR | Breitfeld Philip P. | Dir | M - OptEx | $3.21 | +8,333 | 18.2K | +84% | +$26.7K |
| D | 2022-10-14 | 2022-10-12 | CSBR | SIDRANSKY DAVID | Dir | M - OptEx | $3.21 | +8,333 | 770.6K | +1% | +$26.7K |
| D | 2022-10-14 | 2022-10-12 | CSBR | SIDRANSKY DAVID | Dir | F - Tax | $7.51 | -3,562 | 767.0K | -0.5% | -$26.8K |
| D | 2022-10-13 | 2022-10-12 | CSBR | TOBIN SCOTT R | Dir | M - OptEx | $3.21 | +10.0K | 30.0K | +50% | +$32.1K |
| D | 2021-10-19 | 2021-10-15 | CSBR | SIDRANSKY DAVID | Dir | M - OptEx | $1.59 | +16.7K | 764.9K | +2% | +$26.5K |
| D | 2021-10-19 | 2021-10-15 | CSBR | SIDRANSKY DAVID | Dir | F - Tax | $10.08 | +2,629 | 762.3K | +0.3% | +$26.5K |
| D | 2021-10-13 | 2021-10-12 | CSBR | TOBIN SCOTT R | Dir | M - OptEx | $1.59 | +10.0K | 20.0K | +100% | +$15.9K |
Purchase Sale Sale after option exercise All abbreviations